ZCT — Zero Candida Technologies Share Price
Last trade - 00:00- CA$6.18m
- CA$6.20m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Jul | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zero Candida Technologies Inc. is a technology company. The Company is focused on commercial exploitation of a number of patents and patent applications with respect to an artificial intelligence (AI) smart tampon-like device, designed to treat Candidiasis and transfer the medical information through Wi-Fi to the doctor. Its technology is a combination of a therapy light source with a selected wavelength and intensity and a transparent gel-based drug delivery system to maintain the optimum Ph level in the vagina. The device, when used overnight, demonstrated 99.9999% Candidiasis elimination in the vagina within 3 nights. The device is based on smart technology that distributes light and a sensor that gathers and conveys data. The technology and the sensor itself are both patented, and together they provide focused and precise treatment, supported by scientific data. The ZC Device is designed to be re-used, such that the user only needs to clean or replace the coating before each use.
Directors
- Last Annual
- July 31st, 2024
- Last Interim
- October 31st, 2024
- Incorporated
- August 13th, 2021
- Public Since
- November 25th, 2024
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 19,627,856
- Address
- 1 Adelaide Street East, Suite 801, TORONTO, M5C 2V9
- Web
- https://zero-candida.com/
- Phone
- Auditors
- Stern & Lovrics LLP
Similar to ZCT
Aurora Spine
TSX Venture Exchange
CardioComm Solutions
TSX Venture Exchange
Conavi Medical
TSX Venture Exchange
Covalon Technologies
TSX Venture Exchange
EvokAI Creative Labs
TSX Venture Exchange
FAQ
As of Today at 24:15 UTC, shares in Zero Candida Technologies are trading at CA$0.32. This share price information is delayed by 15 minutes.
Shares in Zero Candida Technologies last closed at CA$0.32 and the price had moved by over the past 365 days. In terms of relative price strength the Zero Candida Technologies share price has matched the Toronto Stock Exchange 300 Composite Index by over the past year.
There is no consensus recommendation for this security.
Find out moreZero Candida Technologies does not currently pay a dividend.
Zero Candida Technologies does not currently pay a dividend.
Zero Candida Technologies does not currently pay a dividend.
To buy shares in Zero Candida Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.32, shares in Zero Candida Technologies had a market capitalisation of CA$6.18m.
Here are the trading details for Zero Candida Technologies:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: ZCT
Based on an overall assessment of its quality, value and momentum Zero Candida Technologies is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zero Candida Technologies. Over the past six months, its share price has matched the Toronto Stock Exchange 300 Composite Index by .
As of the last closing price of CA$0.32, shares in Zero Candida Technologies were trading -60.72% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Zero Candida Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.32.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Zero Candida Technologies' directors